|
Ernest Armstrong, as CEO of Gene Pharmaceuticals, LLC, has overseen clinical research on allergic rhinitis products and out-licensed medical technology to Cobalis Corp. From 1991 through 1996, Mr. Armstrong was Founder and President of Broncorp, Inc., a research-based pharmaceutical company focused on drug-delivery technologies and on developing treatments for asthma and allergy. He was an Associate Professor of International Business at Dai-lchi Economics College, Fukuoka, Japan 1998-1991. Mr. Armstrong speaks seven languages and previously lived in Canada, France, Guatemala, Italy, Japan and Switzerland. His education includes: BA, International Marketing and core courses for BS in Biology Humboldt State University, Arcata, California; BA, French, University of Aix-en-Provence France; MBA, San Francisco State University. Mr. Armstrong is the Project Director for Cobalis Corp’s Phase III Clinical Trials for the Company’s flagship product PreHistin. | 